Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Pulmonary Hypertension, March 2019

Free Subscription


Abstracts

Retrieve all available abstracts of the following 132 articles:
HTML format


 

Single Articles

  1. LI T, Peng JJ, Wang EL, Li NS, et al
    Magnesium Lithospermate B Derived from Salvia miltiorrhiza Ameliorates Right Ventricle Remodeling in Pulmonary Hypertensive Rats via Inhibition of NOX/VPO1 Pathway.
    Planta Med. 2019 Mar 1. doi: 10.1055/a-0863-4741.
    Abstract    

    Abstract available

  2. DOCHERTY CK, Nilsen M, MacLean MR
    Influence of 2-Methoxyestradiol and Sex on Hypoxia-Induced Pulmonary Hypertension and Hypoxia-Inducible Factor-1-alpha.
    J Am Heart Assoc. 2019;8:e011628.
    Abstract    

    Abstract available

  3. IVARSSON B, Sjoberg T, Hesselstrand R, Radegran G, et al
    Everyday life experiences of spouses of patients who suffer from pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension.
    ERJ Open Res. 2019;5.
    Abstract    

    Abstract available

  4. ALDURAIBI A, Fathala A
    Normal ventilation/perfusion lung scan in patients with extensive chronic thromboembolism pulmonary hypertension: A case report.
    Radiol Case Rep. 2019;14:510-513.
    Abstract    

    Abstract available

  5. CAGLAYAN E, Trappiel M, Behringer A, Berghausen EM, et al
    Pulmonary arterial remodelling by deficiency of peroxisome proliferator-activated receptor-gamma in murine vascular smooth muscle cells occurs independently of obesity-related pulmonary hypertension.
    Respir Res. 2019;20:42.
    Abstract    

    Abstract available

  6. CHEN X, Zhou W, Hu Q, Huang L, et al
    Exploration of the Notch3-HES5 signal pathway in monocrotaline-induced pulmonary hypertension using rat model.
    Congenit Heart Dis. 2019 Feb 27. doi: 10.1111/chd.12733.
    Abstract    

    Abstract available

  7. COSTE F, Benlala I, Dournes G, Dromer C, et al
    Quantitative CT assessment of bronchial and vascular alterations in severe precapillary pulmonary hypertension.
    Int J Chron Obstruct Pulmon Dis. 2019;14:381-389.
    Abstract    

    Abstract available

  8. RABER L, Ueki Y, Lang IM
    Balloon Pulmonary Angioplasty for the Treatment of Chronic Thromboembolic Pulmonary Hypertension.
    EuroIntervention. 2019 Feb 26. pii: EIJ-D-18-01212. doi: 10.4244/EIJ-D-18-01212.
    Abstract    



  9. AHN CM, Hiromi M
    Chronic Thromboembolic Pulmonary Hypertension: Endovascular Treatment.
    Korean Circ J. 2019;49:214-222.
    Abstract    

    Abstract available

  10. HUANG J, Frid M, Gewitz MH, Fallon JT, et al
    EXPRESS: Hypoxia-induced Pulmonary Hypertension and Chronic Lung Disease: Caveolin-1 Dysfunction an Important Underlying Feature.
    Pulm Circ. 2019 Feb 26:2045894019837876. doi: 10.1177/2045894019837876.
    Abstract    



  11. THOMAZ AM, Kajita LJ, Aiello VD, Zorzanelli L, et al
    EXPRESS: Parameters associated with outcome in pediatric patients with congenital heart disease and pulmonary hypertension subjected to combined vasodilator and surgical treatments.
    Pulm Circ. 2019 Feb 26:2045894019837885. doi: 10.1177/2045894019837885.
    Abstract    



  12. VAN DER GRAAF M, Rojer LA, Helbing W, Reiss I, et al
    EXPRESS: Sildenafil for bronchopulmonary dysplasia and pulmonary hypertension: a meta-analysis.
    Pulm Circ. 2019 Feb 26:2045894019837875. doi: 10.1177/2045894019837875.
    Abstract    



  13. LI C, Zhao JL, Liu S, Wang Q, et al
    [The clinical characteristics of antiphospholipid syndrome associated with chronic thromboembolic pulmonary hypertension].
    Zhonghua Nei Ke Za Zhi. 2019;58:198-201.
    Abstract    

    Abstract available

  14. LUCAS DJ, Rubinstein J, Gosain A, Tiao G, et al
    Surgical and anesthetic management for hepatectomy in two pediatric patients with trisomy 18, pulmonary hypertension, and hepatoblastoma.
    Pediatr Blood Cancer. 2019 Feb 25:e27678. doi: 10.1002/pbc.27678.
    Abstract    

    Abstract available

  15. IKUBO Y, Kasai H, Sugiura T, Saito T, et al
    Pulmonary Hypertension that Developed During Treatment for Hepatopulmonary Syndrome and Pulmonary Arteriovenous Malformation.
    Intern Med. 2019 Feb 25. doi: 10.2169/internalmedicine.1993.
    Abstract    

    Abstract available

  16. BREDMOSE PP, Buskop C, Lomo AB
    Inhaled nitric oxide might be a contributing tool for successful resuscitation of cardiac arrest related to pulmonary hypertension.
    Scand J Trauma Resusc Emerg Med. 2019;27:22.
    Abstract    

    Abstract available

  17. ZHOU Y, Shao L, Ruan W, Jin J, et al
    Pulmonary vascular involvement of IgG4-related disease: Case series with a PRISMA-compliant systemic review.
    Medicine (Baltimore). 2019;98:e14437.
    Abstract    

    Abstract available

  18. YANG S, Wu J, Lei S, Song R, et al
    Abnormal pulmonary artery systolic pressure response after exercise in systemic sclerosis patients: A PRISMA-compliant meta-analysis.
    Medicine (Baltimore). 2019;98:e14342.
    Abstract    

    Abstract available

  19. NAKAMURA H, Zimmer J, Friedmacher F, Puri P, et al
    Expression of Nitric Oxide Synthase Interacting Protein (NOSIP) is Decreased in the Pulmonary Vasculature of Nitrofen-Induced Congenital Diaphragmatic Hernia.
    Eur J Pediatr Surg. 2018 Dec 10. doi: 10.1055/s-0038-1675772.
    Abstract    

    Abstract available

  20. DUAN B, Ni YH, Dai YQ, Xu ZM, et al
    [Clinical evaluation of vocal fold paralysis in 207 children].
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018;53:847-850.
    Abstract    

    Abstract available

  21. FISCHER L, Benjamin N, Blank N, Egenlauf B, et al
    Right heart size and function significantly correlate in patients with pulmonary arterial hypertension - a cross-sectional study.
    Respir Res. 2018;19:216.
    Abstract    

    Abstract available

  22. ZHANG XF, Yang Y, Yang XY, Tong Q, et al
    LEF-1 gene silencing inhibits pulmonary vascular remodeling and occurrence of pulmonary arterial hypertension through the beta-catenin signaling pathway.
    Biomed Pharmacother. 2018;108:817-827.
    Abstract    

    Abstract available

  23. TAKATSUKI S, Yanai S, Ikehara S, Nakayama T, et al
    Clinical Effects of Syncope on Disease Severity and Adverse Outcomes in Children with Idiopathic and Heritable Pulmonary Arterial Hypertension.
    Pediatr Cardiol. 2019;40:209-214.
    Abstract    

    Abstract available

  24. LIANG L, Su H, Ma X, Zhang R, et al
    Good response to PAH-targeted drugs in a PVOD patient carrying Biallelic EIF2AK4 mutation.
    Respir Res. 2018;19:192.
    Abstract    

    Abstract available

  25. STARK VC, Schneider EP, Biermann D, Hauck PA, et al
    Alveolar capillary dysplasia with left heart obstruction - rare but lethal.
    J Neonatal Perinatal Med. 2018;11:289-293.
    Abstract    

    Abstract available

  26. MENG ML, Fu A, Westhoff C, Bacchetta M, et al
    Eisenmenger Syndrome in Pregnancy: When Is It Time for ECMO?: A Case Report.
    A A Pract. 2018;11:270-272.
    Abstract    

    Abstract available

  27. LIANG KW, Huang CY, Jan SL, Wang KY, et al
    Vascular Plugging for the Enlarging Pulmonary Arteriovenous Malformation in a Patient With Idiopathic Pulmonary Artery Hypertension.
    Can J Cardiol. 2018;34:812.
    Abstract    

    Abstract available

  28. LEVY PT, Patel MD, Choudhry S, Hamvas A, et al
    Evidence of Echocardiographic Markers of Pulmonary Vascular Disease in Asymptomatic Infants Born Preterm at One Year of Age.
    J Pediatr. 2018 Apr 3. pii: S0022-3476(18)30182.
    Abstract    

    Abstract available

  29. MIRZA H, Garcia JA, Crawford E, Pepe J, et al
    Natural History of Postnatal Cardiopulmonary Adaptation in Infants Born Extremely Preterm and Risk for Death or Bronchopulmonary Dysplasia.
    J Pediatr. 2018 Apr 3. pii: S0022-3476(18)30222.
    Abstract    

    Abstract available

  30. CAREY WA, Weaver AL, Mara KC, Clark RH, et al
    Inhaled Nitric Oxide in Extremely Premature Neonates With Respiratory Distress Syndrome.
    Pediatrics. 2018 Feb 9. pii: peds.2017-3108. doi: 10.1542/peds.2017-3108.
    Abstract    

    Abstract available

  31. HERBERT LM, Resta TC, Jernigan NL
    RhoA increases ASIC1a plasma membrane localization and calcium influx in pulmonary arterial smooth muscle cells following chronic hypoxia.
    Am J Physiol Cell Physiol. 2018;314:C166-C176.
    Abstract    

    Abstract available

  32. LEWCZUK N, Zdebik A, Boguslawska J, Turno-Krecicka A, et al
    Ocular manifestations of pulmonary hypertension.
    Surv Ophthalmol. 2019 Mar 5. pii: S0039-6257(18)30280.
    Abstract    

    Abstract available

  33. BERGHAUSEN EM, Feik L, Zierden M, Vantler M, et al
    Key inflammatory pathways underlying vascular remodeling in pulmonary hypertension.
    Herz. 2019 Mar 7. pii: 10.1007/s00059-019-4795-6. doi: 10.1007/s00059-019-4795.
    Abstract    

    Abstract available

  34. OHASHI K, Nishimura R, Sugimoto S, Sakao S, et al
    Effectiveness of pulmonary vasodilators on pulmonary hypertension associated with POEMS syndrome.
    Respirol Case Rep. 2019;7:e00411.
    Abstract    

    Abstract available

  35. SHIBATA A, Mori H, Kodo K, Nakanishi T, et al
    Polysplenia Syndrome as a Risk Factor for Early Progression of Pulmonary Hypertension.
    Circ J. 2019 Mar 5. doi: 10.1253/circj.CJ-18-0933.
    Abstract    

    Abstract available

  36. HUETSCH JC, Suresh K, Shimoda LA
    Regulation of Smooth Muscle Cell Proliferation by NADPH Oxidases in Pulmonary Hypertension.
    Antioxidants (Basel). 2019;8.
    Abstract    

    Abstract available

  37. BECIROVIC-AGIC M, Jonsson S, Tveitaras MK, Skogstrand T, et al
    Time-course of decompensation after angiotensin II and high-salt diet in Balb/CJ mice suggests pulmonary hypertension-induced cardiorenal syndrome.
    Am J Physiol Regul Integr Comp Physiol. 2019.
    Abstract    

    Abstract available

  38. YADLAPATI A, Wax D, Rich S, Ricciardi MJ, et al
    Novel shunt modification with an adjustable stent-embedded "fenestrated" septal occluder in a patient with pulmonary hypertension.
    Catheter Cardiovasc Interv. 2019 Mar 6. doi: 10.1002/ccd.28169.
    Abstract    

    Abstract available

  39. MURAKI Y, Naito T, Tohyama K, Shibata S, et al
    Improvement of pulmonary arterial hypertension, inflammatory response, and epithelium injury by dual activation of cAMP/cGMP pathway in a rat model of monocrotaline-induced pulmonary hypertension.
    Biosci Biotechnol Biochem. 2019 Mar 5:1-11. doi: 10.1080/09168451.2019.1584520.
    Abstract    

    Abstract available

  40. WANG XY, Mo D, Tian W, Liu XX, et al
    Inhibition of RhoA/ROCK signaling pathway ameliorates hypoxic pulmonary hypertension via HIF-1alpha-dependent functional TRPC channels.
    Toxicol Appl Pharmacol. 2019 Mar 1. pii: S0041-008X(19)30074.
    Abstract    

    Abstract available

  41. MANJUBASHINI D, Nagarajan K, Rajesh Kumar B
    Pulmonary capillary hemangiomatosis: An unusual cause of primary pulmonary hypertension in a child with characteristic computed tomography imaging features.
    Lung India. 2019;36:157-159.
    Abstract    

    Abstract available

  42. BASYAL B, Jarrett H, Barnett CF
    Pulmonary Hypertension in HIV.
    Can J Cardiol. 2019;35:288-298.
    Abstract    

    Abstract available

  43. SMITS J, Tasev D, Andersen S, Szulcek R, et al
    Blood Outgrowth and Proliferation of Endothelial Colony Forming Cells are Related to Markers of Disease Severity in Patients with Pulmonary Arterial Hypertension.
    Int J Mol Sci. 2018;19.
    Abstract    

    Abstract available

  44. DANIEL MC, Adams GGW, Dahlmann-Noor A
    Medical Management of Children With Congenital/Infantile Cataract Associated With Microphthalmia, Microcornea, or Persistent Fetal Vasculature.
    J Pediatr Ophthalmol Strabismus. 2019;56:43-49.
    Abstract    

    Abstract available

  45. AMBADE AS, Jung B, Lee D, Doods H, et al
    Triple-tyrosine kinase inhibition attenuates pulmonary arterial hypertension and neointimal formation.
    Transl Res. 2019;203:15-30.
    Abstract    

    Abstract available

  46. ZHUANG W, Lian G, Huang B, Du A, et al
    Pulmonary arterial hypertension induced by a novel method: Twice-intraperitoneal injection of monocrotaline.
    Exp Biol Med (Maywood). 2018;243:995-1003.
    Abstract    

    Abstract available

  47. PAN J, Lei L, Zhao C
    Comparison between the efficacy of combination therapy and monotherapy in connective tissue disease associated pulmonary arterial hypertension: a systematic review and meta-analysis.
    Clin Exp Rheumatol. 2018;36:1095-1102.
    Abstract    

    Abstract available

  48. KAZIMIERCZYK R, Kaminski K
    The role of platelets in the development and progression of pulmonary arterial hypertension.
    Adv Med Sci. 2018;63:312-316.
    Abstract    

    Abstract available

  49. LEE WS, Wong SY, Ivy DD, Sokol RJ, et al
    Hepatopulmonary Syndrome and Portopulmonary Hypertension in Children: Recent Advances in Diagnosis and Management.
    J Pediatr. 2018 Mar 5. pii: S0022-3476(17)31763.
    Abstract    



  50. PULIGANDLA PS, Skarsgard ED, Offringa M, Adatia I, et al
    Diagnosis and management of congenital diaphragmatic hernia: a clinical practice guideline.
    CMAJ. 2018;190:E103-E112.
    Abstract    



  51. HEKIMSOY V, Kaya EB, Akdogan A, Sahiner L, et al
    Echocardiographic assessment of regional right ventricular systolic function using two-dimensional strain echocardiography and evaluation of the predictive ability of longitudinal 2D-strain imaging for pulmonary arterial hypertension in systemic scler
    Int J Cardiovasc Imaging. 2018;34:883-892.
    Abstract    

    Abstract available

  52. LITTMANN L, Potter JK, Hoglund JR
    Profound Electrocardiogram Changes in a Patient With Liver Cirrhosis.
    JAMA Intern Med. 2018;178:286-288.
    Abstract    



  53. SENER YZ, Oksul M, Hekimsoy V
    Right heart catheterization datas may not reflect the pulmonary hypertension epidemiology accurately.
    Turk Kardiyol Dern Ars. 2019;47:157.
    Abstract    



  54. FRANK BS, Schafer M, Grenolds A, Ivy DD, et al
    Acute Vasoreactivity Testing during Cardiac Catheterization of Neonates with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension.
    J Pediatr. 2019 Mar 11. pii: S0022-3476(18)31721.
    Abstract    

    Abstract available

  55. KEEPANASSERIL A, Pillai AA, Yavanasuriya J, Raj A, et al
    Outcome of pregnancies in women with Pulmonary Hypertension: A Single Centre Experience from South India.
    BJOG. 2019 Mar 14. doi: 10.1111/1471-0528.15681.
    Abstract    

    Abstract available

  56. DENG Y, Guo SL, Wei B, Gao XC, et al
    Activation of Nicotinic Acetylcholine alpha7 Receptor Attenuates Progression of Monocrotaline-Induced Pulmonary Hypertension in Rats by Downregulating the NLRP3 Inflammasome.
    Front Pharmacol. 2019;10:128.
    Abstract    

    Abstract available

  57. VAN THOR MCJ, Ten Klooster L, Snijder RJ, Post MC, et al
    Long-term clinical value and outcome of riociguat in chronic thromboembolic pulmonary hypertension.
    Int J Cardiol Heart Vasc. 2019;22:163-168.
    Abstract    

    Abstract available

  58. PARIKH KS, Dahhan T, Nicholl L, Ruopp N, et al
    Clinical Features and Outcomes of Patients with Sarcoidosis-associated Pulmonary Hypertension.
    Sci Rep. 2019;9:4061.
    Abstract    

    Abstract available

  59. SUGAWARA Y, Mizuno Y, Oku S, Goto T, et al
    Effects of vasopressin during a pulmonary hypertensive crisis induced by acute hypoxia in a rat model of pulmonary hypertension.
    Br J Anaesth. 2019;122:437-447.
    Abstract    

    Abstract available

  60. GONG J, Chen Z, Chen Y, Lv H, et al
    Long non-coding RNA CASC2 suppresses pulmonary artery smooth muscle cell proliferation and phenotypic switch in hypoxia-induced pulmonary hypertension.
    Respir Res. 2019;20:53.
    Abstract    

    Abstract available

  61. WATANABE K, Ito N, Ohata T, Kariya T, et al
    Preoperative balloon pulmonary angioplasty enabled noncardiac surgery of a patient with chronic thromboembolic pulmonary hypertension (CTEPH): A case report.
    Medicine (Baltimore). 2019;98:e14807.
    Abstract    

    Abstract available

  62. ESTEPHAN LE, Genuardi MV, Kosanovich C, Risbano MG, et al
    EXPRESS: Distinct plasma gradients of microRNA-204 in the pulmonary circulation of patients suffering from WHO Groups I and II pulmonary hypertension.
    Pulm Circ. 2019 Mar 11:2045894019840646. doi: 10.1177/2045894019840646.
    Abstract    



  63. MARTIN-SUAREZ S, Gliozzi G, Fiorentino M, Loforte A, et al
    Role and management of extracorporeal life support after surgery of chronic thromboembolic pulmonary hypertension.
    Ann Cardiothorac Surg. 2019;8:84-92.
    Abstract    

    Abstract available

  64. FUKUDA K, Date H, Doi S, Fukumoto Y, et al
    Guidelines for the Treatment of Pulmonary Hypertension (JCS 2017/JPCPHS 2017).
    Circ J. 2019 Mar 9. doi: 10.1253/circj.CJ-66-0158.
    Abstract    



  65. KHAN MS, Amin E, Memon MM, Yamani N, et al
    Meta-analysis of use of balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension.
    Int J Cardiol. 2019 Feb 23. pii: S0167-5273(18)36648.
    Abstract    

    Abstract available

  66. KHIRFAN G, Ahmed MK, Faulx MD, Dakkak W, et al
    Gasometric gradients between blood obtained from the pulmonary artery wedge and pulmonary artery positions in pulmonary arterial hypertension.
    Respir Res. 2019;20:6.
    Abstract    

    Abstract available

  67. PURVIS J
    Oxygen: both friend and foe.
    Ulster Med J. 2018;87:153-154.
    Abstract    



  68. SHIRAISHI J, Kusuda S, Cho K, Nakao A, et al
    Standardization of nitric oxide inhalation in extremely preterm infants in Japan.
    Pediatr Int. 2019;61:152-157.
    Abstract    

    Abstract available

  69. WANG S, Yu M, Zheng X, Dong S, et al
    A Bayesian network meta-analysis on the efficacy and safety of eighteen targeted drugs or drug combinations for pulmonary arterial hypertension.
    Drug Deliv. 2018;25:1898-1909.
    Abstract    

    Abstract available

  70. ARAUJO IT, Lembi PJ, Falchetto EB, Correa RA, et al
    Left main coronary artery compression in a patient with portopulmonary hypertension.
    J Bras Pneumol. 2018;44:337-338.
    Abstract    



  71. KUMAR S, Vadlamudi K, Kaddoura T, Bobhate P, et al
    Active right atrial emptying fraction predicts reduced survival and increased adverse events in childhood pulmonary arterial hypertension.
    Int J Cardiol. 2018;271:306-311.
    Abstract    

    Abstract available

  72. DEDANIA VS, Ozgonul C, Besirli CG
    Peripheral Persistent Fetal Vasculature: A Report of Three Cases.
    Ophthalmic Surg Lasers Imaging Retina. 2018;49:e83-e88.
    Abstract    

    Abstract available

  73. AKAGI K, Tanaka T, Baba S
    Successful living donor liver transplantation after stent implantation in a patient with Alagille syndrome and severe bilateral pulmonary artery stenosis.
    Cardiol Young. 2018;28:1465-1467.
    Abstract    

    Abstract available

  74. TOK PL, Roy DM, Ng AK, Vasudevan AR, et al
    Normotensive Scleroderma Renal Crisis.
    Ann Acad Med Singapore. 2018;47:223-225.
    Abstract    



  75. GHIO S, Fortuni F, Greco A, Turco A, et al
    Dobutamine stress echocardiography in pulmonary arterial hypertension.
    Int J Cardiol. 2018;270:331-335.
    Abstract    

    Abstract available

  76. WU WH, Yuan P, Zhang SJ, Jiang X, et al
    Impact of Pituitary-Gonadal Axis Hormones on Pulmonary Arterial Hypertension in Men.
    Hypertension. 2018 Apr 30. pii: HYPERTENSIONAHA.118.10963.
    Abstract    

    Abstract available

  77. SHARMA H, Chinnappan M, Agarwal S, Dalvi P, et al
    Macrophage-derived extracellular vesicles mediate smooth muscle hyperplasia: role of altered miRNA cargo in response to HIV infection and substance abuse.
    FASEB J. 2018;32:5174-5185.
    Abstract    

    Abstract available

  78. LUSSKIN SI, Khan SJ, Ernst C, Habib S, et al
    Pharmacotherapy for Perinatal Depression.
    Clin Obstet Gynecol. 2018;61:544-561.
    Abstract    

    Abstract available

  79. ZAPOL WM, Charles HC, Martin AR, Sa RC, et al
    Pulmonary Delivery of Therapeutic and Diagnostic Gases.
    J Aerosol Med Pulm Drug Deliv. 2018;31:78-87.
    Abstract    

    Abstract available

  80. MUSA BM, Odoh CN, Galadanci NA, Saidu H, et al
    Lower than expected elevated tricuspid regurgitant jet velocity in adults with sickle cell disease in Nigeria.
    Int Health. 2018;10:356-362.
    Abstract    

    Abstract available

  81. LEPPER PM, Horsch SI, Seiler F, Kamp A, et al
    Percutaneous Mechanical Circulation Support Combined with Extracorporeal Membrane Oxygenation (oxyRVAD) in Secondary Right Heart Failure.
    ASAIO J. 2018;64:e64-e67.
    Abstract    

    Abstract available

  82. GOHAR S, Taimeh Z, Morgan J, Frazier OH, et al
    Use of Remote Pulmonary Artery Pressure Monitoring (CardioMEMS System) in Total Artificial Heart to Assess Pulmonary Hemodynamics for Heart Transplantation.
    ASAIO J. 2017 Nov 8. doi: 10.1097/MAT.0000000000000726.
    Abstract    

    Abstract available

  83. JOYCE DL, Redfield MM, Kushwaha SS, Behfar A, et al
    Pulmonary Pressure Assessment with the Total Artificial Heart.
    ASAIO J. 2018;64:e34-e36.
    Abstract    

    Abstract available

  84. ARMSTRONG I, Billings C, Kiely DG, Yorke J, et al
    The patient experience of pulmonary hypertension: a large cross-sectional study of UK patients.
    BMC Pulm Med. 2019;19:67.
    Abstract    

    Abstract available

  85. PADERVINSKIENE L, Krivickiene A, Hoppenot D, Miliauskas S, et al
    Prognostic Value of Left Ventricular Function and Mechanics in Pulmonary Hypertension: A Pilot Cardiovascular Magnetic Resonance Feature Tracking Study.
    Medicina (Kaunas). 2019;55.
    Abstract    

    Abstract available

  86. ISOBE S, Kataoka M, Endo J, Moriyama H, et al
    Endothelial-Mesenchymal Transition Drives Expression of CD44 Variant and xCT in Pulmonary Hypertension.
    Am J Respir Cell Mol Biol. 2019 Mar 21. doi: 10.1165/rcmb.2018-0231.
    Abstract    

    Abstract available

  87. YI T, Ma W, Qiu J, Ding W, et al
    Pulmonary hypertension with massive megalosplenia: A case report.
    Medicine (Baltimore). 2019;98:e14594.
    Abstract    

    Abstract available

  88. FAKHRY ABDELMASSIH A, Zahraa Hassan FA, El-Gammal A, Tawfik M, et al
    The overlooked left ventricle in Persistent Pulmonary hypertension of the Newborn.
    J Matern Fetal Neonatal Med. 2019.
    Abstract    

    Abstract available

  89. MASCHKE SK, Winther HMB, Meine T, Werncke T, et al
    Evaluation of a newly developed 2D parametric parenchymal blood flow technique with an automated vessel suppression algorithm in patients with chronic thromboembolic pulmonary hypertension undergoing balloon pulmonary angioplasty.
    Clin Radiol. 2019 Mar 16. pii: S0009-9260(19)30118.
    Abstract    

    Abstract available

  90. LEHNER A, Schulze-Neick I, Fischer M, Fernandez-Rodriguez S, et al
    The Creation of an Interatrial Right-To-Left Shunt in Patients with Severe, Irreversible Pulmonary Hypertension: Rationale, Devices, Outcomes.
    Curr Cardiol Rep. 2019;21:31.
    Abstract    

    Abstract available

  91. IANNUZZI GL, D'Alto M, Formisano R, Maniscalco M, et al
    Biomarkers in clinical management of pulmonary hypertension: has the emperor no clothes? A call for action.
    Biomark Med. 2019 Mar 18. doi: 10.2217/bmm-2018-0491.
    Abstract    



  92. ASIF S, Rasheed A, Mahmud TE, Asghar A, et al
    Frequency and predictors of pulmonary hypertension in patients with Systemic Lupus Erythematosus.
    Pak J Med Sci. 2019;35:86-89.
    Abstract    

    Abstract available

  93. KYLAT RI
    Pulmonary hypertension occurring with diazoxide use in a preterm infant with hypoglycemia.
    Drug Healthc Patient Saf. 2019;11:7-10.
    Abstract    

    Abstract available

  94. KIELY D, Levin D, Hassoun P, Ivy DD, et al
    EXPRESS: Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI).
    Pulm Circ. 2019 Mar 18:2045894019841990. doi: 10.1177/2045894019841990.
    Abstract    



  95. BHATTACHARYA PT, Troutman GS, Mao F, Fox A, et al
    EXPRESS: RIGHT VENTRICULAR OUTFLOW TRACT VELOCITY TIME INTEGRAL- TO- PULMONARY ARTERY SYSTOLIC PRESSURE RATIO: A NONINVASIVE METRIC OF PULMONARY ARTERIAL COMPLIANCE DIFFERS ACROSS THE SPECTRUM OF PULMONARY HYPERTENSION.
    Pulm Circ. 2019 Mar 18:2045894019841978. doi: 10.1177/2045894019841978.
    Abstract    



  96. GOSS KN, Austin E Austin, Battiola TJ, Tepper RS, et al
    EXPRESS: Novel Early Life Risk Factors for Adult Pulmonary Hypertension.
    Pulm Circ. 2019 Mar 18:2045894019842002. doi: 10.1177/2045894019842002.
    Abstract    



  97. JAROENSRI S, Kamolvisit W, Nakwan N
    Risk factor analysis of pneumothorax associated with persistent pulmonary hypertension of the newborn in Thai neonates.
    J Matern Fetal Neonatal Med. 2019.
    Abstract    

    Abstract available

  98. ANDIJANI AA, Shajira ES, Abushaheen A, Al-Matary A, et al
    Microphthalmia Syndrome 9: Case Report of a Newborn Baby with Pulmonary Hypoplasia, Diaphragmatic Eventration, Microphthalmia, Cardiac Defect and Severe Primary Pulmonary Hypertension.
    Am J Case Rep. 2019;20:354-360.
    Abstract    

    Abstract available

  99. TELLO K, Dalmer A, Vanderpool R, Ghofrani HA, et al
    Cardiac Magnetic Resonance Imaging-Based Right Ventricular Strain Analysis for Assessment of Coupling and Diastolic Function in Pulmonary Hypertension.
    JACC Cardiovasc Imaging. 2019 Mar 8. pii: S1936-878X(19)30164.
    Abstract    

    Abstract available

  100. MUNEUCHI J, Ochiai Y, Masaki N, Okada S, et al
    Pulmonary arterial compliance is a useful predictor of pulmonary vascular disease in congenital heart disease.
    Heart Vessels. 2019;34:470-476.
    Abstract    

    Abstract available

  101. DESCHLE HA, Amenabar A, Casso NA, Gantesti J, et al
    Behavior of right atrial strain in high systolic pulmonary artery pressure.
    Echocardiography. 2018;35:1557-1563.
    Abstract    

    Abstract available

  102. ABOU HASSAN OK, Haidar W, Nemer G, Skouri H, et al
    Clinical and genetic characteristics of pulmonary arterial hypertension in Lebanon.
    BMC Med Genet. 2018;19:89.
    Abstract    

    Abstract available

  103. BATTON KA, Austin CO, Bruno KA, Burger CD, et al
    Sex differences in pulmonary arterial hypertension: role of infection and autoimmunity in the pathogenesis of disease.
    Biol Sex Differ. 2018;9:15.
    Abstract    

    Abstract available

  104. RASHID J, Nahar K, Raut S, Keshavarz A, et al
    Fasudil and DETA NONOate, Loaded in a Peptide-Modified Liposomal Carrier, Slow PAH Progression upon Pulmonary Delivery.
    Mol Pharm. 2018;15:1755-1765.
    Abstract    

    Abstract available

  105. EL-KERSH K, Suliman S, Smith JS
    Selexipag in Congenital Heart Disease-Associated Pulmonary Arterial Hypertension and Eisenmenger Syndrome: First Report.
    Am J Ther. 2018;25:e714-e715.
    Abstract    



  106. BILLAR RJ, Leening MJG, Merkus D, Brusselle GGO, et al
    Measures of subclinical cardiac dysfunction and increased filling pressures associate with pulmonary arterial pressure in the general population: results from the population-based Rotterdam Study.
    Eur J Epidemiol. 2018;33:403-413.
    Abstract    

    Abstract available

  107. XIE X, Li S, Zhu Y, Liu L, et al
    Egr-1 mediates leptin-induced PPARgamma reduction and proliferation of pulmonary artery smooth muscle cells.
    Mol Biol Cell. 2018;29:356-362.
    Abstract    

    Abstract available

  108. TOWE CT, White FV, Grady RM, Sweet SC, et al
    Infants with Atypical Presentations of Alveolar Capillary Dysplasia with Misalignment of the Pulmonary Veins Who Underwent Bilateral Lung Transplantation.
    J Pediatr. 2017 Nov 30. pii: S0022-3476(17)31375.
    Abstract    

    Abstract available

  109. MARTIN T, Smith A, Breatnach CR, Kent E, et al
    Infants Born with Down Syndrome: Burden of Disease in the Early Neonatal Period.
    J Pediatr. 2017 Nov 23. pii: S0022-3476(17)31300.
    Abstract    

    Abstract available

  110. JAIN P, Rao S, Macdonald P, Kotlyar E, et al
    Diagnostic Performance of Pulmonary Capacitance at Rest and During Exercise in Idiopathic Pulmonary Arterial Hypertension.
    Heart Lung Circ. 2019;28:289-294.
    Abstract    

    Abstract available

  111. IKEHARA S, Takatsuki S, Nakayama T, Naoi K, et al
    Clinical Impact of Main Pulmonary Artery Dilatation on Outcome in Pediatric Idiopathic and Heritable Pulmonary Arterial Hypertension.
    Circ J. 2018;82:541-545.
    Abstract    

    Abstract available

  112. YASUOKA H, Shirai Y, Tamura Y, Takeuchi T, et al
    Predictors of Favorable Responses to Immunosuppressive Treatment in Pulmonary Arterial Hypertension Associated With Connective Tissue Disease.
    Circ J. 2018;82:546-554.
    Abstract    

    Abstract available

  113. KALRA VK, Zhang S, Malik P, Tahara SM, et al
    Placenta growth factor mediated gene regulation in sickle cell disease.
    Blood Rev. 2018;32:61-70.
    Abstract    

    Abstract available

  114. YAOITA N, Shimokawa H
    Effect of heart rate reduction in pulmonary arterial hypertension.
    Am J Physiol Heart Circ Physiol. 2018;314:H889-H891.
    Abstract    



  115. OMURA J, Bonnet S, Kutty S
    Right Ventricular and Pulmonary Vascular Changes in Pulmonary Hypertension Associated with Left Heart Disease.
    Am J Physiol Heart Circ Physiol. 2019 Mar 15. doi: 10.1152/ajpheart.00159.2019.
    Abstract    



  116. HEWES JL, Bauer NN
    Extracellular Vesicles in Pulmonary Hypertension: Lessons from Mesenchymal Stromal Cell-Derived Exosomes.
    Am J Physiol Lung Cell Mol Physiol. 2019 Mar 13. doi: 10.1152/ajplung.00107.2019
    Abstract    



  117. NOVELLI EM, Little-Ihrig L, Knupp HE, Rogers NM, et al
    Vascular TSP1-CD47 Signaling Promotes Sickle Cell-Associated Arterial Vasculopathy and Pulmonary Hypertension in Mice.
    Am J Physiol Lung Cell Mol Physiol. 2019 Mar 20. doi: 10.1152/ajplung.00302.2018
    Abstract    

    Abstract available

  118. BRAGANZA M, Shaw J, Solverson K, Vis D, et al
    A prospective evaluation of the diagnostic accuracy of the physical examination for pulmonary hypertension.
    Chest. 2019 Feb 28. pii: S0012-3692(19)30204-1. doi: 10.1016/j.chest.2019.
    Abstract    

    Abstract available

  119. BUNEL V, Guyard A, Dauriat G, Danel C, et al
    Pulmonary Arterial Histological Lesions in COPD Patients with Severe Pulmonary Hypertension.
    Chest. 2019 Mar 11. pii: S0012-3692(19)30616-6. doi: 10.1016/j.chest.2019.
    Abstract    

    Abstract available

  120. CULLEY MK, Chan SY
    Human Endogenous Retrovirus K and Pulmonary Arterial Hypertension: A New Take on a Retro Idea.
    Circulation. 2017;136:1936-1938.
    Abstract    



  121. ARCHER SL
    Pyruvate Kinase and Warburg Metabolism in Pulmonary Arterial Hypertension: Uncoupled Glycolysis and the Cancer-Like Phenotype of Pulmonary Arterial Hypertension.
    Circulation. 2017;136:2486-2490.
    Abstract    



  122. GERGES C, Gerges M, Lang IM
    Pulmonary hypertension associated with left heart disease: efforts to improve the meaning of haemodynamic phenotypes.
    Eur Respir J. 2019;53.
    Abstract    



  123. GRIGNOLA JC, Trujillo P, Domingo E
    Pulmonary hypertension associated with left heart disease: efforts to improve the meaning of haemodynamic phenotypes.
    Eur Respir J. 2019;53.
    Abstract    



  124. CASCINO TM, McLaughlin VV, Richardson CR, Behbahani-Nejad N, et al
    Physical activity and quality of life in patients with pulmonary hypertension.
    Eur Respir J. 2019 Mar 17. pii: 13993003.00028-2019.
    Abstract    



  125. DRAKOPOULOU M, Nashat H, Kempny A, Alonso-Gonzalez R, et al
    Arrhythmias in adult patients with congenital heart disease and pulmonary arterial hypertension.
    Heart. 2018;104:1963-1969.
    Abstract    

    Abstract available

  126. BRIDA M, Gatzoulis MA
    Pulmonary arterial hypertension in adult congenital heart disease.
    Heart. 2018;104:1568-1574.
    Abstract    

    Abstract available

  127. KELAVA M, Koprivanac M, Smedira N, Mihaljevic T, et al
    Extracorporeal Membrane Oxygenation in Pulmonary Endarterectomy Patients.
    J Cardiothorac Vasc Anesth. 2019;33:60-69.
    Abstract    

    Abstract available

  128. LIN CH, Reardon MJ
    Commentary: Chronic thromboembolic pulmonary hypertension in Austria and Japan: The Sound of Music meets Madame Butterfly.
    J Thorac Cardiovasc Surg. 2019 Jan 31. pii: S0022-5223(19)30294.
    Abstract    



  129. CHEMLA D, Berthelot E, Assayag P, Attal P, et al
    [Pathophysiology of right ventricular hemodynamics].
    Rev Mal Respir. 2018;35:1050-1062.
    Abstract    

    Abstract available

  130. CORRAL-BLANCO M, Prudencio-Ribera VC, Jarrin-Estupinan ME, Alonso-Moralejo R, et al
    Influence of Pulmonary Hypertension on Intrahospital Mortality in Lung Transplantation for Interstitial Lung Disease.
    Transplant Proc. 2019;51:380-382.
    Abstract    

    Abstract available

  131. FUJITA N, Yamasaki N, Eto K, Asaeda M, et al
    Oxygen therapy may worsen the survival rate in rats with monocrotaline-induced pulmonary arterial hypertension.
    PLoS One. 2018;13:e0204254.
    Abstract    

    Abstract available

  132. ZANTE B, Reichenspurner H, Kubik M, Kluge S, et al
    Base excess is superior to lactate-levels in prediction of ICU mortality after cardiac surgery.
    PLoS One. 2018;13:e0205309.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;